Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
International Journal of Clinical Practice|May 12, 2010
An obesity drug sibutramine reduces brain natriuretic peptide (BNP) levels in severely obese patientsD Taner Ertugrul, B Yavuz, K Okhan Akin, et al.
Acta Gastro-Enterologica Belgica|January 25, 2018
The role of insulin - like growth factor - 1 on steatohepatitisK Dal, O Bulur, N Ata, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 14, 2021
Biodistribution of surfactant-free poly(lactic-acid) nanoparticles and uptake by endothelial cells and phagocytes in zebrafish: Evidence for endothelium to macrophage transferJulien Rességuier, Jean-Pierre Levraud, Nils K Dal, et al.
BMJ Quality & Safety|December 10, 2023
Retrospective cohort study of wrong-patient imaging order errors: how many reach the patient?Jerard Z Kneifati-Hayek, Elias Geist, Jo R Applebaum, et al.
Biomacromolecules|February 21, 2019
Rifampicin Nanoformulation Enhances Treatment of Tuberculosis in ZebrafishJiří Trousil, Zdeňka Syrová, Nils-Jørgen K Dal, et al.
European Journal of Medicinal Chemistry|February 13, 2026
New antitubercular pretomanid analogues as potent payloads in polymeric micelles: Leveraging zebrafish assays to accelerate lead optimisationAndrew M Thompson, Nils-Jørgen K Dal, Francesca Boldrin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 21, 2023
Π-Π interactions stabilize PeptoMicelle-based formulations of Pretomanid derivatives leading to promising therapy against tuberculosis in zebrafish and mouse modelsNils-Jørgen K Dal, Gabriela Schäfer, Andrew M Thompson, et al.
Epilepsy Research|February 5, 2013
Fish oil attenuates methylmalonate-induced seizuresCristina Ruedell Reschke Banderó, Mirian G S S Salvadori, Anajara Teixeira Gomes, et al.
AAPS Pharmscitech|June 8, 2023
Inhaled Adjunct Therapy with Second-Line Drug Candidates for Dose Reduction in Chemotherapeutic Regimens for Multi-drug-Resistant TuberculosisSonia Verma, Nils-Jorgen K Dal, Ashish Srivastava, et al.
Pageof 2